Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma

E. Chiefari, D. Russo, D. Giuffrida, G. A. Zampa, D. Meringolo, R. Arturi, I. Chiodini, D. Bianchi, M. Attard, V. Trischitta, R. Bruno, P. Giannasio, A. Pontecorvi, S. Filetti

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Medullary thyroid carcinoma (MTC) may occur either as a sporadic or familial (FMTC) disease. Multiple endocrine neoplasia (MEN) type 2, inherited as an autosomal dominant disease, is characterized by coexistence of MTC with other endocrine neoplasia. Activating mutations of the RET proto-oncogene, involving the somatic or the germinal cell lineage, are found in both inherited and acquired forms. In this study, RET mutations were screened in 47 individuals either affected by MTC or belonging to families with hereditary MTC. Exons 10, 11, 13, 14, 15 and 16 of the RET gene were amplified by polymerase chain reaction and examined by DNA sequence and/or restriction enzyme analysis to detect mutations in purified amplicons. Six MEN 2A families with germline mutation at codon 634, one FMTC family carrying a mutation at codon 618 and two MEN 2B families with a mutation at codon 918 were identified. In affected members of a MEN 2A family no known RET mutations were observed. Besides, we identified a germline mutation in a patient with apparently sporadic MTC and in two out of three sons, indicating the presence of a sporadic misclassified familial disease. In all of the families examined we were able to distinguish the affected vs unaffected (not at risk) members. A somatic mutation of codon 918 was detected in three out of ten patients with apparently sporadic MTC.

Original languageEnglish
Pages (from-to)358-364
Number of pages7
JournalJournal of Endocrinological Investigation
Volume21
Issue number6
Publication statusPublished - Jun 1998

Fingerprint

Multiple Endocrine Neoplasia
Proto-Oncogenes
Mutation
Codon
Germ-Line Mutation
Multiple Endocrine Neoplasia Type 2a
Restriction Mapping
Cell Lineage
Medullary Thyroid cancer
Nuclear Family
Exons
Polymerase Chain Reaction

Keywords

  • Genetic analysis
  • Medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia (MEN)
  • Mutation
  • Restriction analysis
  • RET proto-oncogene

ASJC Scopus subject areas

  • Endocrinology

Cite this

Chiefari, E., Russo, D., Giuffrida, D., Zampa, G. A., Meringolo, D., Arturi, R., ... Filetti, S. (1998). Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. Journal of Endocrinological Investigation, 21(6), 358-364.

Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. / Chiefari, E.; Russo, D.; Giuffrida, D.; Zampa, G. A.; Meringolo, D.; Arturi, R.; Chiodini, I.; Bianchi, D.; Attard, M.; Trischitta, V.; Bruno, R.; Giannasio, P.; Pontecorvi, A.; Filetti, S.

In: Journal of Endocrinological Investigation, Vol. 21, No. 6, 06.1998, p. 358-364.

Research output: Contribution to journalArticle

Chiefari, E, Russo, D, Giuffrida, D, Zampa, GA, Meringolo, D, Arturi, R, Chiodini, I, Bianchi, D, Attard, M, Trischitta, V, Bruno, R, Giannasio, P, Pontecorvi, A & Filetti, S 1998, 'Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma', Journal of Endocrinological Investigation, vol. 21, no. 6, pp. 358-364.
Chiefari, E. ; Russo, D. ; Giuffrida, D. ; Zampa, G. A. ; Meringolo, D. ; Arturi, R. ; Chiodini, I. ; Bianchi, D. ; Attard, M. ; Trischitta, V. ; Bruno, R. ; Giannasio, P. ; Pontecorvi, A. ; Filetti, S. / Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. In: Journal of Endocrinological Investigation. 1998 ; Vol. 21, No. 6. pp. 358-364.
@article{ab42649eae92489c98ce13f7f7764e2f,
title = "Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma",
abstract = "Medullary thyroid carcinoma (MTC) may occur either as a sporadic or familial (FMTC) disease. Multiple endocrine neoplasia (MEN) type 2, inherited as an autosomal dominant disease, is characterized by coexistence of MTC with other endocrine neoplasia. Activating mutations of the RET proto-oncogene, involving the somatic or the germinal cell lineage, are found in both inherited and acquired forms. In this study, RET mutations were screened in 47 individuals either affected by MTC or belonging to families with hereditary MTC. Exons 10, 11, 13, 14, 15 and 16 of the RET gene were amplified by polymerase chain reaction and examined by DNA sequence and/or restriction enzyme analysis to detect mutations in purified amplicons. Six MEN 2A families with germline mutation at codon 634, one FMTC family carrying a mutation at codon 618 and two MEN 2B families with a mutation at codon 918 were identified. In affected members of a MEN 2A family no known RET mutations were observed. Besides, we identified a germline mutation in a patient with apparently sporadic MTC and in two out of three sons, indicating the presence of a sporadic misclassified familial disease. In all of the families examined we were able to distinguish the affected vs unaffected (not at risk) members. A somatic mutation of codon 918 was detected in three out of ten patients with apparently sporadic MTC.",
keywords = "Genetic analysis, Medullary thyroid carcinoma, Multiple Endocrine Neoplasia (MEN), Mutation, Restriction analysis, RET proto-oncogene",
author = "E. Chiefari and D. Russo and D. Giuffrida and Zampa, {G. A.} and D. Meringolo and R. Arturi and I. Chiodini and D. Bianchi and M. Attard and V. Trischitta and R. Bruno and P. Giannasio and A. Pontecorvi and S. Filetti",
year = "1998",
month = "6",
language = "English",
volume = "21",
pages = "358--364",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "6",

}

TY - JOUR

T1 - Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma

AU - Chiefari, E.

AU - Russo, D.

AU - Giuffrida, D.

AU - Zampa, G. A.

AU - Meringolo, D.

AU - Arturi, R.

AU - Chiodini, I.

AU - Bianchi, D.

AU - Attard, M.

AU - Trischitta, V.

AU - Bruno, R.

AU - Giannasio, P.

AU - Pontecorvi, A.

AU - Filetti, S.

PY - 1998/6

Y1 - 1998/6

N2 - Medullary thyroid carcinoma (MTC) may occur either as a sporadic or familial (FMTC) disease. Multiple endocrine neoplasia (MEN) type 2, inherited as an autosomal dominant disease, is characterized by coexistence of MTC with other endocrine neoplasia. Activating mutations of the RET proto-oncogene, involving the somatic or the germinal cell lineage, are found in both inherited and acquired forms. In this study, RET mutations were screened in 47 individuals either affected by MTC or belonging to families with hereditary MTC. Exons 10, 11, 13, 14, 15 and 16 of the RET gene were amplified by polymerase chain reaction and examined by DNA sequence and/or restriction enzyme analysis to detect mutations in purified amplicons. Six MEN 2A families with germline mutation at codon 634, one FMTC family carrying a mutation at codon 618 and two MEN 2B families with a mutation at codon 918 were identified. In affected members of a MEN 2A family no known RET mutations were observed. Besides, we identified a germline mutation in a patient with apparently sporadic MTC and in two out of three sons, indicating the presence of a sporadic misclassified familial disease. In all of the families examined we were able to distinguish the affected vs unaffected (not at risk) members. A somatic mutation of codon 918 was detected in three out of ten patients with apparently sporadic MTC.

AB - Medullary thyroid carcinoma (MTC) may occur either as a sporadic or familial (FMTC) disease. Multiple endocrine neoplasia (MEN) type 2, inherited as an autosomal dominant disease, is characterized by coexistence of MTC with other endocrine neoplasia. Activating mutations of the RET proto-oncogene, involving the somatic or the germinal cell lineage, are found in both inherited and acquired forms. In this study, RET mutations were screened in 47 individuals either affected by MTC or belonging to families with hereditary MTC. Exons 10, 11, 13, 14, 15 and 16 of the RET gene were amplified by polymerase chain reaction and examined by DNA sequence and/or restriction enzyme analysis to detect mutations in purified amplicons. Six MEN 2A families with germline mutation at codon 634, one FMTC family carrying a mutation at codon 618 and two MEN 2B families with a mutation at codon 918 were identified. In affected members of a MEN 2A family no known RET mutations were observed. Besides, we identified a germline mutation in a patient with apparently sporadic MTC and in two out of three sons, indicating the presence of a sporadic misclassified familial disease. In all of the families examined we were able to distinguish the affected vs unaffected (not at risk) members. A somatic mutation of codon 918 was detected in three out of ten patients with apparently sporadic MTC.

KW - Genetic analysis

KW - Medullary thyroid carcinoma

KW - Multiple Endocrine Neoplasia (MEN)

KW - Mutation

KW - Restriction analysis

KW - RET proto-oncogene

UR - http://www.scopus.com/inward/record.url?scp=0031850609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031850609&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 358

EP - 364

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 6

ER -